Loading...
Toxicities associated with PD-1/PD-L1 blockade
Immune checkpoint inhibitors, particularly those targeting PD-1/PD-L1, produce durable responses in a subset of patients across cancer types. Although often well-tolerated, these agents can induce a broad spectrum of autoimmune-like complications that may affect any organ system. Treatment of these...
Na minha lista:
| Udgivet i: | Cancer J |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5784852/ https://ncbi.nlm.nih.gov/pubmed/29360726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000296 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|